Next-generation LMP2A-targeting TCR-recombinant T cells with inducible IL-18 expression to treat EBV-associated malignancies.
- DOI
- 10.1016/j.omton.2026.201265
- Published
- 2026 Sep 17
- Container
- Molecular therapy. Oncology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.omton.2026.201265,
title = {Next-generation LMP2A-targeting TCR-recombinant T cells with inducible IL-18 expression to treat EBV-associated malignancies.},
author = {Bonifacius A and Mausberg P and Floegel F and Dragon AC and Tischer-Zimmermann S and Stoll S and Rahmati P and Spieler P and Lammoglia Cobo MF and Halenius A and Abken H and Blasczyk R and Nerreter T and Hudecek M and Schambach A and Hansmann L and Maecker-Kolhoff B and Eiz-Vesper B},
year = {2026},
journal = {Molecular therapy. Oncology},
doi = {10.1016/j.omton.2026.201265},
url = {https://doi.org/10.1016/j.omton.2026.201265}
}RIS
TY - JOUR TI - Next-generation LMP2A-targeting TCR-recombinant T cells with inducible IL-18 expression to treat EBV-associated malignancies. AU - Bonifacius A AU - Mausberg P AU - Floegel F AU - Dragon AC AU - Tischer-Zimmermann S AU - Stoll S AU - Rahmati P AU - Spieler P AU - Lammoglia Cobo MF AU - Halenius A AU - Abken H AU - Blasczyk R AU - Nerreter T AU - Hudecek M AU - Schambach A AU - Hansmann L AU - Maecker-Kolhoff B AU - Eiz-Vesper B PY - 2026 JO - Molecular therapy. Oncology DO - 10.1016/j.omton.2026.201265 UR - https://doi.org/10.1016/j.omton.2026.201265 ER -
APA
A, B., P, M., F, F., AC, D., S, T., S, S., P, R., P, S., MF, L. C., A, H., H, A., R, B., T, N., M, H., A, S., L, H., B, M., & B, E. (2026). Next-generation LMP2A-targeting TCR-recombinant T cells with inducible IL-18 expression to treat EBV-associated malignancies.. Molecular therapy. Oncology. https://doi.org/10.1016/j.omton.2026.201265
Source records
- pubmed · retrieved 2026-09-25T19:25:27.400Z